Rare Disease Education: Infantile Neuroaxonal Dystrophy
Editor: Kelsey LaFayette, DNP, RN, FNP-C
As we pass the halfway point for the SDGs, many of the goals are worryingly off track and progress on 85% of the target indicators has stalled or even reversed. Through our information, products and people, RELX remains committed to advancing the Goals. Here are some of the ways that we continue to support their achievement.
This study supports SDG 3 by providing data on the prevalence and characteristics of occult hepatitis B virus infection.
This article supports SDG 3 by providing global prevalence data on occult HBV infection in younger populations.
This study supports SDG 3 by developing predictive tools for treatment outcomes in chronic hepatitis B patients.
Access to information is critical in achieving the SDGs - empowering the public to make decisions, informing policy making and enabling effective implementation and monitoring. RELX businesses regularly produce and publish free to download reports and analytics that draw upon vast amounts of information and data in support of the SDGs. Explore some of the reports and tools developed to date.
This study supports SDG 3 by investigating the relationship between NAFLD and liver fibrosis in chronic hepatitis B patients.
Strigolactones (SLs) are a new class of plant hormones that play a significant role in regulating various aspects of plant growth promotion, stress tolerance and influence the rhizospheric microbiome. GR24 is a synthetic SL analog used in scientific research to understand the effects of SL on plants and to act as a plant growth promoter.
Plants have a microbiome, a diverse community of microorganisms, including bacteria, fungi, and viruses, living inside and on their tissues. This review article contains deeper insight in endomicrobiome related research work in last years, recruitment, niche development, nutrient dynamics, stress removal mechanisms, bioactive services in plant health development, community architecture and communication, and immunity interplay in producing stress resilient future crop.
Women interact with cancer in complex ways, as healthy individuals participating in cancer prevention, as patients, as health professionals, researchers, policymakers, and as unpaid caregivers. In all these domains, women often are subject to overlapping forms of discrimination, such as due to age, race, ethnicity and socio-economic status, that render them structurally marginalized. Women, power and cancer: A Lancet Commission recommends that sex and gender be included in all cancer-related policies and guidelines, making these responsive to the needs and aspirations of women in all their diversities. It identifies ten priority actions stakeholder groups can take towards lasting and impactful change.
